tiprankstipranks
Trending News
More News >
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market

SynAct Pharma AB (SYNACT) Income Statement

Compare
0 Followers

SynAct Pharma AB Income Statement

Last quarter (Q4 2024), SynAct Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, SynAct Pharma AB's net income was kr-18.38M. See SynAct Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 0.00kr -778.00Kkr -1.06Mkr -88.00Kkr 0.00
Operating Expenses
kr 89.98Mkr 224.50Mkr 105.71Mkr 76.70Mkr 31.29M
Depreciation and Amortization
kr 74.58Mkr 778.00Kkr 1.06Mkr 88.00Kkr 381.06K
EBITDA
kr -15.40Mkr -222.70Mkr -105.71Mkr -76.62Mkr -30.90M
Operating Income
kr -89.98Mkr -224.50Mkr -105.70Mkr -76.70Mkr -31.29M
Other Income/Expenses
kr -845.00Kkr 220.00Kkr -1.36Mkr -110.00Kkr -19.00K
Pretax Income
kr -90.83Mkr -224.28Mkr -107.06Mkr -76.81Mkr -31.30M
Net Income
kr -82.40Mkr -215.81Mkr -99.20Mkr -69.30Mkr -26.55M
Per Share Metrics
Basic EPS
kr -2.08kr -6.64kr -3.60kr -2.67kr -1.23
Diluted EPS
kr -2.08kr -6.64kr -3.60kr -2.67kr -1.23
Weighted Average Shares Outstanding
39.53M 32.52M 27.59M 25.97M 21.65M
Weighted Average Shares Outstanding (Diluted)
39.53M 32.52M 27.59M 25.97M 21.65M
Currency in SEK

SynAct Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis